Submission Details

Submitter:

Classification:
Moderate
GENCC:100003
Gene:
Disease:
dilated cardiomyopathy
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
08/23/2024
Evidence/Notes:

MYZAP was evaluated for autosomal recessive (AR) dilated cardiomyopathy (DCM). MYZAP is an intercalated disc (ID) protein that is required to maintain cardiac function. MYZAP is strongly expressed in the heart and localizes to the ID. At the time of this review, dilated cardiomyopathy is the only condition that has been associated with this gene.

At least 5 variants (all predicted or proven null) have been reported in humans with DCM. Two Spanish sibs with compound heterozygous LOF variants (one canonical splice donor and one novel nonsense) and DCM diagnosed in their 30’s. Western blot showed low expression of the splice variant and immunofluorescence testing showed abnormal subcellular localization of the nonsense variant (Ochoa et. al, 2024, PMID: 38436102). Two Slovenian siblings with severe, early-onset DCM and a novel homozygous truncating MYZAP variant. IHC and Western blot showed complete absence of MYZAP protein in the proband’s sample (Maver et. al, 2022, PMID: 35840178). Two Finnish families with two different homozygous truncating variants and a total of 4 individuals with confirmed DCM. Myocardium samples showed loss of myzap-staining compared to controls (Helio et. al, 2021, PMID: 34899865).

In addition, these gene-disease assertion is supported by expression studies and animal models. MYZAP KO zebrafish developed cardiomyopathy with pericardial edema and loss of contractility with normal morphology and severe skeletal muscle dysfunction (Seeger et. al, 2010, PMID: 20093627).

In summary, there is moderate evidence to support this gene-disease relationship. more evidence is needed to establish the relationship between MYZAP and AR DCM definitively. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on 08/23/2024 (SOP Version 10).

PubMed IDs:
20093627 34899865 35840178 38436102
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.